Matthew Autterson is the current president and chief executive officer of CNS Bio science. He also was appointed to the Board of directors of the company. The chief executive is an alma mater of the University of Denver Graduate Tax program and the prestigious Michigan State University where he graduated with a B.A. in finance in the year 1980.
Before joining adaptive Bio systems, Mathew Autterson has served in several other companies in various leadership positions. He was the president of the Resources Trust company between 1986 and 1989 before the company was taken over and a series of other by AIG in 1998. The notable crossing deal between AIG and SunAmerica, Inc. which had taken over BroadInc, was estimated to be worth $18b, exemplifying the magnanimity of the chief executive role in the Trust industry. The chief executive is therefore incredibly an experienced trust leader.
He also held positions at First Trust Corporation, which was a subsidiary of the Fiserv two years after his graduation. Later, he left the company and together with other was instrumental in chartering a Colorado State Chartered trust company which was a subsidiary of New York Integrated Resources INC
Together with Holly Kylberg and a team of four others they participated in the Nordstrom Opening where they raced the famous 1296 mile off road race in Mexico to pursue his philanthropic course further and promulgate his advocacy in the current company.
In CNS Bioscience Inc., Mathew Autterson has been an instrumental leader bringing about a wealthy of skills in advocacy as well as managerial skills to the board. His role has provided the company with the much-desired strategy guidance on key issues. His prudence in economic leadership in previous companies has always come at hand for the company. He sits on the board to represent the interest of his philanthropic course though. Before joining this company, the CEO has provided a leadership role in similar organizations such as Denver Zoo and Denver Hospice amongst many others.
The company he currently serves as president and chief executive officer was founded in 2013 by Scott Falci M.D. It is a clinical stage drug advancement company that has mainly focused on neuropathic pain. He is also a managing partner at GL3B Limited, LLP, from 2001 to date. The CEO attended Brother Rice High school and hailed from Detroit in Michigan. He currently resides in Cherry Hills Village in Colorado.